China Registry for Genetic / Metabolic Liver Diseases

NCT03131427 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Friendship Hospital

Phase

Observational

Started

2015-06-13

Last updated

2017-04-27

Condition(s) studied

Genetic/Metabolic Liver Diseases

Investigational drug(s) / intervention(s)

Standard of care

Standard of care: Standard of care according to the updated national and/or international guidelines

Study summary

CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: Patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or other genetic/metabolic liver diseases. Exclusion Criteria: Patients who are unable or unwilling to provide informed consent.

Primary outcome measure(s)

rate of liver-related events of each disease. — 10 years
Rates of cirrhosis, decompensation and hepatocellular carcinoma.

Trial sites (12)

Facility	City	Region	Status
Beijing Ditan Hospital	Beijing	Beijing Municipality	Recruiting
Beijing Anzhen Hospital, Capital Medical University	Beijing	Beijing Municipality	Recruiting
Peking University First Hospital	Beijing	Beijing Municipality	Recruiting
Beijing YouAn Hospital	Beijing	Beijing Municipality	Recruiting
Nanfang Hospital of Southern Medical University	Guangzhou	Guangdong	Recruiting
Hebei Medical University Third Hospital	Shijiazhuang	Hebei	Recruiting
Henan Provincial Hospital	Zhengzhou	Henan	Recruiting
Zhongshan Hospital, Fudan University	Shanghai	Shanghai Municipality	Recruiting
Jinshan Hospital of Fudan University	Shanghai	Shanghai Municipality	Recruiting
West China Women's and Children's Hospital, Sichuan University	Chengdu	Sichuan	Recruiting
Affiliated Hospital, Logistics University of People's Armed Police Force	Tianjin	Tianjin Municipality	Recruiting
Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital	Ürümqi	Xinjiang	Recruiting

More Beijing Friendship Hospital trials in China

Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset Recruiting

Beijing Friendship Hospital Metabolic Surgery Database Recruiting

BeijngFH Health Cohort Study Recruiting

Clinical Classification of MAFLD Based Liver Biopsy Starting soon

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03131427 on ClinicalTrials.gov ↗ ← All trials in China